| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/21/2004 | CA2505707A1 Method of detecting bone paget's disease |
| 05/21/2004 | CA2505326A1 Camelidae antibodies against immunoglobulin e and use thereof for the treatment of allergic disorders |
| 05/21/2004 | CA2505325A1 Stabilized single domain antibodies |
| 05/21/2004 | CA2505316A1 Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor |
| 05/21/2004 | CA2505208A1 Hiv vaccine |
| 05/21/2004 | CA2504926A1 Compositions and methods for sirna inhibition of hif-1 alpha |
| 05/21/2004 | CA2504922A1 Methods for the identification of agents that modulate the structure and processing of a membrane bound precursor protein |
| 05/21/2004 | CA2504915A1 Allele-specific rna interference |
| 05/21/2004 | CA2504870A1 Methods for the identification of agents that modulate the structure and processing of beta-amyloid precursor protein |
| 05/21/2004 | CA2504867A1 Transgenic mammal carrying ganp gene transferred thereinto and utilization thereof |
| 05/21/2004 | CA2504694A1 Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation |
| 05/21/2004 | CA2504593A1 Synthetic muscle promoters with activities exceeding naturally occurring regulatory sequences in cardiac cells |
| 05/21/2004 | CA2504350A1 Apkc isoforms in nervous system disorders and cancer |
| 05/21/2004 | CA2504270A1 Peptide fragments of the harp factor inhibiting angiogenesis |
| 05/21/2004 | CA2503964A1 Pain relief agents |
| 05/21/2004 | CA2503546A1 Pharmaceutical composition for preparing a medicine for treating and/or preventing a pathology related to an obsessive behaviour or obesity |
| 05/21/2004 | CA2503390A1 Compositions and methods for the treatment of immune related diseases |
| 05/21/2004 | CA2501523A1 Human type ii diabetes gene-kv channel-interacting protein (kchip1) located on chromosome 5 |
| 05/21/2004 | CA2483481A1 Method for diagnosing and monitoring cardiac transplant rejection |
| 05/20/2004 | US20040098769 Comprises nucleotide sequences coding single-stranded DNA-binding protein for modulating DNA replication, repair and recombination; tissue engineering |
| 05/20/2004 | US20040098767 Comprises nucleotide sequences coding protein intermediate-1 for use in modifying flowering in plants |
| 05/20/2004 | US20040098764 Plant transcriptional regulators of abiotic stress |
| 05/20/2004 | US20040098763 Modulation of plant cyclin-dependent kinase inhibitor activity |
| 05/20/2004 | US20040098762 Comprises nucleotide sequences coding desaturase for insertion of a double bond into a fatty acyl moiety at the twelfth or fifteenth carbon position in fatty acyl chain; improving vegetable oils |
| 05/20/2004 | US20040098761 Compositions and methods for controlling parasitic nematodes |
| 05/20/2004 | US20040098760 Transcriptional regulatory nucleic acids, polypeptides and methods of use thereof |
| 05/20/2004 | US20040098759 Comprises expression vector coding nucleotide sequences for heavy metal transporting P type membrane pump protein for transformation and propagation of crops resistant to heavy metal poisoning and uptake; bioremediation |
| 05/20/2004 | US20040098758 Method for modifying a plant phenotype |
| 05/20/2004 | US20040098757 Rodent model homozygous for membrane protein defect associated with angina and arrhythmias for identifying modulators of cardiovascular and cardiac disorders |
| 05/20/2004 | US20040098756 Transgenic animals for use in protein expression and antibody production |
| 05/20/2004 | US20040098755 Comprises nucleotide sequences coding embryonic glycoprotein for use in the treatment and prevention of autoimmune, cell proliferative and immunological disorders; immunosuppressants; antiproliferative agents |
| 05/20/2004 | US20040098119 Stent with smooth ends |
| 05/20/2004 | US20040097722 Preparation of phosphorothioate oligomers |
| 05/20/2004 | US20040097721 Pesticidal toxins and genes from Bacillus laterosporus strains |
| 05/20/2004 | US20040097718 Complete nucleotide sequence of staphlococcus aureus ribosomal protein gene, s20 and methods for the identification of antibacterial substances |
| 05/20/2004 | US20040097717 Comprises nucleotide sequences coding polypeptide associated with abscisic acid (ABA) biosynthesis and for controlling preharvest sprouting in plants; agriculture and genetic engineering |
| 05/20/2004 | US20040097708 Comprises nucleotide sequences coding membrane protein associated with odor detection for use in biological pest control |
| 05/20/2004 | US20040097706 Streptococcus pyogenes antigens and corresponding dna fragments |
| 05/20/2004 | US20040097705 Small acid-soluble spore protein and uses thereof |
| 05/20/2004 | US20040097659 Polyethylene glycol containing sugar residue and carboxylic acid side chains; drug delivery and gene transfer carrier; aggregation inhibition; expression efficiency; water solubility |
| 05/20/2004 | US20040097459 Modulation of forkhead box O1A expression |
| 05/20/2004 | US20040097458 Providing microprojectiles carrying polynucleic acid sequences; accelerating the microprojectiles at the preselected-cells, with the microprojectiles contacting cells to penetrate vertebrate cells and deposit polynucleic acid |
| 05/20/2004 | US20040097457 Protein disulfide isomerase and abc transporter homologous proteins involved in the regulation of energy homeostasis |
| 05/20/2004 | US20040097455 Cloning of reporter genes and cDNA encoding for therapeutic proteins for the treatment of hepatic, pulmonary, renal, heart, pancreas fibrosis, keloids and hypertrophic scars, in mammals, including human beings |
| 05/20/2004 | US20040097452 Modulation of kallikrein 6 expression |
| 05/20/2004 | US20040097451 Modulation of nidogen expression |
| 05/20/2004 | US20040097450 Modulation of TDP-1 expression |
| 05/20/2004 | US20040097449 Modulation of KIAA0415 expression |
| 05/20/2004 | US20040097448 Modulation of CD24 expression |
| 05/20/2004 | US20040097447 For therapy of autoimmune disorder |
| 05/20/2004 | US20040097446 Modulation of checkpoint kinase 1 expression |
| 05/20/2004 | US20040097445 For therapy of hyperproliferative disorder |
| 05/20/2004 | US20040097444 Modulation of serine/threonine kinase 16 expression |
| 05/20/2004 | US20040097443 Modulation of jerky-like 1 expression |
| 05/20/2004 | US20040097442 For prophylaxis and therapy of cancer |
| 05/20/2004 | US20040097441 Modulation of NIMA-related kinase 6 expression |
| 05/20/2004 | US20040097440 Modulation of jumonji expression |
| 05/20/2004 | US20040097439 Useful to study, increase and/or reduce genes expression, and to improve DNA vaccination |
| 05/20/2004 | US20040097414 Genetic engineered Dna; gene therapy |
| 05/20/2004 | US20040097412 Non-mammalian GnRH analogs and uses thereof in tumor cell growth regulation and cancer therapy |
| 05/20/2004 | US20040097409 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 05/20/2004 | US20040097393 Use of a single cellulase with a ratio of tensile strength loss to antipilling properties in aqueous laundry solutions |
| 05/20/2004 | US20040096974 Methods and materials for generating genetic disruptions in bacterial cells |
| 05/20/2004 | US20040096973 Diagnosing and preventing microorganismal infections using iron-restricted conditions; genetic vaccines |
| 05/20/2004 | US20040096972 Chimeric plasmid comprising a replicative retroviral genome, and uses |
| 05/20/2004 | US20040096971 Using cortical and/or medullary thymic epithelial cells to propagate lymphocytes and generate T cells from hematopoietic stem cells |
| 05/20/2004 | US20040096965 Activator of fibronectin binding protein and method of its preparation |
| 05/20/2004 | US20040096956 Trangenic cells for generation of immunoglobulins for detection, quantitation, purification and neutralization of antigens; therapeutic diagnostics |
| 05/20/2004 | US20040096955 Methods and compositions for determining isomerase enzymatic activity |
| 05/20/2004 | US20040096945 Nucleic acids and protein variants of hG-CSF with granulopoietic activity |
| 05/20/2004 | US20040096942 Chimeric retinoid X receptors and their use in a novel ecdysone receptor-based inducible gene expression system |
| 05/20/2004 | US20040096941 Comprise phytosulfokine (PSK) receptor protein for regulating plant growth rates |
| 05/20/2004 | US20040096940 Novel polypeptides having opioid receptor activity, nucleic acids coding therefor and uses thereof |
| 05/20/2004 | US20040096939 Modifier of organelle metabolism |
| 05/20/2004 | US20040096938 Method for generating split, non-transferable genes that are able to express an active protein product |
| 05/20/2004 | US20040096936 Comprises nucleotide sequences coding fibroblast growth factor (FGF) for treating cardiac disorders; tissue engineering; tissue-targeted gene therapy |
| 05/20/2004 | US20040096934 Pepsin-sensitive modified Bacillus thuringiensis insecticidal toxin |
| 05/20/2004 | US20040096929 Enzymatic cycling assays for homocysteine and cystathionine |
| 05/20/2004 | US20040096921 Human plasma hyaluronidase |
| 05/20/2004 | US20040096901 Chineric monocllonal antibody for treatment and prevention transplant rejection, psoriasis, inflammatory bowel, autoimmune and allergic disorders |
| 05/20/2004 | US20040096895 Biosensor with covalently attached membrane-spanning proteins |
| 05/20/2004 | US20040096891 Inserting nucleotide sequences into chromosomes using site specific recombinases; genetic engineering and cloning |
| 05/20/2004 | US20040096889 Compositions, organisms and methodologies employing a novel human kinase |
| 05/20/2004 | US20040096888 Comprises nucleotide sequences coding cyclin dependent kinase (PELOTA) for diagnosis, treatment, prognosis and prevention of cell proliferative, cardoivascular, inflammatory, arthritic disorders |
| 05/20/2004 | US20040096886 Using sodium channel (SCNA) expresion to detect nervous system disorders; antitpileptic agents |
| 05/20/2004 | US20040096885 Using sodium channel (SCNA) expresion to detect nervous system disorders; antitpileptic agents |
| 05/20/2004 | US20040096883 Scanned image alignment systems and methods |
| 05/20/2004 | US20040096882 For injectable solutions; MRNA translation/degradation control |
| 05/20/2004 | US20040096881 For prophylactics/diagnostics/therapeutics; endothelial nitric oxide synthase (eNOS) |
| 05/20/2004 | US20040096879 Method for detecting a biological entity in a sample |
| 05/20/2004 | US20040096878 For anticancer/tumor agents; in vivo gene expression profiling; solid phase synthesis |
| 05/20/2004 | US20040096877 For diagnosis/treatment/prevention of inflammation/asthma/ allergies |
| 05/20/2004 | US20040096875 Comprises polynucleotide derived from rise; genetic engineering |
| 05/20/2004 | US20040096870 Methods of detecting sequence differences |
| 05/20/2004 | US20040096869 For protection of cells against damage/death which characterize stroke, myocardial infarction, Parkinson's disease, Alzheimer's disease, multiple sclerosis, and arthritis |
| 05/20/2004 | US20040096868 For diagnosis/treatment of cancer; drugs; kits; cell-free analysis; solid phase synthesis |
| 05/20/2004 | US20040096865 For diagnosis/preventing/treating central nervous system disorders/obesity/diabetes; cell-free; solid phase synthesis; kits |
| 05/20/2004 | US20040096864 Method of eukaryotic expression cloning of disease associated molecules |
| 05/20/2004 | US20040096863 Methods and kits for determining a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a dna repair enzyme and a cancer |
| 05/20/2004 | US20040096862 Novel protein and dna encoding the same |